Literature DB >> 31465542

Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.

Zhiquan Chen1,2,3, Xiaohong Sun1,3, Qiuhong Chen1, Tian Lan4, Kaipeng Huang5, Haiming Xiao1, Zeyuan Lin1, Yan Yang1, Peiqing Liu1, Heqing Huang1,3.   

Abstract

BACKGROUND AND
PURPOSE: Nox4 is the major isoform of NADPH oxidase found in the kidney and contributes to the pathogenesis of diabetic nephropathy. However, the molecular mechanisms of increased Nox4 expression induced by hyperglycaemia remain to be elucidated. Here, the role of the connexin32-Nox4 signalling axis in diabetic nephropathy and its related mechanisms were investigated. EXPERIMENTAL APPROACH: Diabetes was induced in mice by low-dose streptozotocin (STZ) combined with a high-fat diet. Effects of connexin32 on Nox4 expression and on renal function and fibrosis in STZ-induced diabetic mice were investigated using adenovirus-overexpressing connexin32 and connexin32-deficient mice. Interactions between connexin32 and Nox4 were analysed by co-immunoprecipitation and immunofluorescence assays. KEY
RESULTS: Connexin32 was down-regulated in the kidneys of STZ-induced diabetic mice. Overexpression of connexin32 reduced expression of Nox4 and improved renal function and fibrosis in diabetic mice, whereas connexin32 deficiency had opposite effects. Down-regulation of fibronectin expression by connexin32 was not dependent on gap junctional intercellular communication involving connexin32. Connexin32 interacted with Nox4 and reduced the generation of hydrogen peroxide, leading to the down-regulation of fibronectin expression. Mechanistically, connexin32 decreased Nox4 expression by promoting its K48-linked polyubiquitination. Interestingly, Smurf1 overexpression inhibited K48-linked polyubiquitination of Nox4. Furthermore, connexin32 interacted with Smurf1 and inhibited its expression. CONCLUSION AND IMPLICATIONS: Connexin32 ameliorated renal fibrosis in diabetic mice by promoting K48-linked Nox4 polyubiquitination and degradation via inhibition of Smurf1 expression. Targeting the connexin32-Nox4 signalling axis may contribute to the development of novel treatments for diabetic nephropathy.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31465542      PMCID: PMC6976783          DOI: 10.1111/bph.14853

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

Review 1.  Connexins and cell signaling in development and disease.

Authors:  Chih-Jen Wei; Xin Xu; Cecilia W Lo
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

2.  Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury.

Authors:  Sunmi Palumbo; Yoon-Joo Shin; Kareem Ahmad; Ankit A Desai; Hector Quijada; Mohamed Mohamed; Adam Knox; Saad Sammani; Brett A Colson; Ting Wang; Joe G N Garcia; Louise Hecker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

3.  Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.

Authors:  M Sedeek; G Callera; A Montezano; A Gutsol; F Heitz; C Szyndralewiez; P Page; C R J Kennedy; K D Burns; R M Touyz; R L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-14

Review 4.  Oxidative stress as a major culprit in kidney disease in diabetes.

Authors:  Josephine M Forbes; Melinda T Coughlan; Mark E Cooper
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

5.  CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.

Authors:  Wenyan Gong; Zhiquan Chen; Yezi Zou; Lei Zhang; Junying Huang; Peiqing Liu; Heqing Huang
Journal:  Free Radic Biol Med       Date:  2017-12-14       Impact factor: 7.376

6.  Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice.

Authors:  E Nelles; C Bützler; D Jung; A Temme; H D Gabriel; U Dahl; O Traub; F Stümpel; K Jungermann; J Zielasek; K V Toyka; R Dermietzel; K Willecke
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Negative regulation of NADPH oxidase 4 by hydrogen peroxide-inducible clone 5 (Hic-5) protein.

Authors:  Leena P Desai; Yong Zhou; Aida V Estrada; Qiang Ding; Guangjie Cheng; James F Collawn; Victor J Thannickal
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

8.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 9.  Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.

Authors:  Stacey Ruiz; Pablo E Pergola; Richard A Zager; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; O Peter Buneman; John A Cidlowski; Arthur Christopoulos; Anthony P Davenport; Doriano Fabbro; Michael Spedding; Jörg Striessnig; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

View more
  5 in total

1.  Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.

Authors:  Zhiquan Chen; Xiaohong Sun; Qiuhong Chen; Tian Lan; Kaipeng Huang; Haiming Xiao; Zeyuan Lin; Yan Yang; Peiqing Liu; Heqing Huang
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

2.  FOXA1 Suppresses SATB1 Transcription and Inactivates the Wnt/β-Catenin Pathway to Alleviate Diabetic Nephropathy in a Mouse Model.

Authors:  Hong Zhu; Jiarui Peng; Wei Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-10       Impact factor: 3.168

3.  miR-154-5p Affects the TGFβ1/Smad3 Pathway on the Fibrosis of Diabetic Kidney Disease via Binding E3 Ubiquitin Ligase Smurf1.

Authors:  Che Bian; Zhilin Luan; Haibo Zhang; Ruijing Zhang; Jing Gao; Yuxia Wang; Jia Li; Huiwen Ren
Journal:  Oxid Med Cell Longev       Date:  2022-01-27       Impact factor: 6.543

4.  Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.

Authors:  Haiming Xiao; Xiaohong Sun; Zeyuan Lin; Yan Yang; Meng Zhang; Zhanchi Xu; Peiqing Liu; Zhongqiu Liu; Heqing Huang
Journal:  Acta Pharm Sin B       Date:  2022-01-06       Impact factor: 14.903

5.  Connexin mRNA distribution in adult mouse kidneys.

Authors:  Lisa Geis; Franz-Fabian Boudriot; Charlotte Wagner
Journal:  Pflugers Arch       Date:  2021-08-07       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.